ArticleIDCases2025
Serial computed tomography imaging of splenic infarction associated with Epstein-Barr virus infection.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 30-year-old previously healthy man presented with a 10-day history of fever, generalized fatigue, sore throat, and arthralgia. Physical examination revealed tender cervical lymphadenopathy and right upper abdominal discomfort on palpation. Laboratory tests showed a white blood cell count of 12,100 cells/µL with 21 % atypical lymphocytes, and elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels at 174 U/L and 339 U/L, respectively. Contrast-enhanced abdominal computed tomography (CT) performed to evaluate the abdominal discomfort revealed hepatosplenomegaly and a wedge-shaped low-attenuation area in the spleen, consistent with splenic infarction. Subsequent serologic testing was positive for Epstein-Barr virus (EBV) viral capsid antigen immunoglobulin M (IgM) and negative for Epstein-Barr nuclear antigen antibodies, confirming a diagnosis of primary EBV infection. The patient subsequently became afebrile, his symptoms resolved spontaneously, and his AST and ALT levels normalized. Follow-up CT imaging showed a slight reduction in the size of the splenic infarction at 5 weeks, and a marked reduction at 8 weeks. Splenic infarction is a rare but recognized complication of primary EBV infection. Although it generally has a favorable prognosis, careful clinical monitoring is essential due to the potential risk of splenic rupture, which may necessitate splenectomy. Some cases have been treated with anticoagulation therapy; however, most, including this patient, improve with supportive care alone. This case highlights the spontaneous healing of EBV-associated splenic infarction demonstrated through serial imaging and suggests that follow-up imaging may be unnecessary in the absence of abdominal symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.